PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.\', \'Division of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: vkyttari@bidmc.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(21)00234-510.1016/j.clim.2021.108897
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 34848357
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all